Pharmaceutical Executive Bioethics Roundtable

Bioethics International & Yale School of Medicine’s Pharmaceutical Executive Roundtable

Hosted by Deloitte

This year’s bioethics roundtable, our 12th!, will focus on equity and social responsibility in the bio-pharmaceutical sector and debut the new Good Pharma Scorecard (GPS) company rankings on diversity and fair inclusion in research.

Featured Speakers

  • Neil Lesser, Principal, Life Sciences R&D and Sustainability/Equity Practice Leader, Deloitte
  • Jennifer E. Miller, Associate Professor, Yale School of Medicine; Founder, Bioethics International
  • Kimberly Sabelko, VP, Scientific Strategy & Programs, Susan G. Komen Foundation
  • David Leventhal, Enterprise Clinical Trial Data Sharing Lead, Pfizer, Inc.
  • Martin Mendoza, Director Health Equity, All of Us Research Program, NIH
  • Patrice Matchaba, Head, US Corporate Responsibility; President, Novartis Foundation
  • Pierre Theodore, VP, Global Public Health, Johnson & Johnson
  • Jessica Scott, President, Legacy Health Strategies
  • Marc Wilenzick, Associate General Counsel, Gilead
  • Catharine Grimes, President, Bristol Myers Squibb Foundation
  • Lauren Puffer, Director, Sustainability Banking, Cowen

When: June 9, 2022 – 9am-4:15pm ET

Location: Deloitte’s NYC Offices

Register Here: Pharma Executive Roundtable RSVP Form

BI Roundtable Flyer